Seller: Vineet D. Menachery
Contact Seller / Seller’s Other Items / Save This Seller
Condition: toxic
Time Left: 11 days, 3 hours
Bids: [28] Bidder List
Current Bid: $1,450,000,000
Location: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Shipping: Buyer responsible for securing Infectious Substance Special Permits from US and foreign agencies as required. Laboratory materials will only be released to be preapproved DOT-SP 16279 companies.
Whether you are planning a false flag operation, working on global population reduction, or selling billions of doses of untested vaccines under emergency approval, this enhanced COVID genome will provide everything you need.
The COVID-22 virus has the following benefits:
Documentation includes complete genetic sequencing with enhanced receptor binding domains (RBD) and maximized up receptors via enhancements to spike proteins K417N and N501Y, full documentation of all non-structural protein modifications and amino acid inserts, and nucleocapsid modifications for increased resistance to antigenetic agents.
Live virus samples will be delivered separately from the data.
